Results 21 to 30 of about 3,072,312 (306)

Diagnostic and prognostic biomarkers for chronic fibrosing interstitial lung diseases with a progressive phenotype [PDF]

, 2020
Biomarkers have the potential to become central to the clinical evaluation and monitoring of patients with chronic fibrosing interstitial lung diseases with a progressive phenotype.
Inoue, Y., Kaner, R. J., Maher, Toby M, Moiseev, S., Maher, T. M., Brown, K. K., Kaner, Robert J, Inoue, Yoshikazu, Tomassetti, Sara, Moiseev, Sergey, Kuwana, Masataka, Kuwana, M., Guiot, Julien, Brown, Kevin K, Tomassetti, S.   +14 more
core   +1 more source

Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis

EJNMMI Research, 2019
Background 18F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glycolysis of the
Milou C. Schimmelpennink, Adriane D. M. Vorselaars, Marcel Veltkamp, Ruth G. M. Keijsers   +3 more
doaj   +1 more source

Prognostic Predictive Characteristics in Patients With Fibrosing Interstitial Lung Disease: A Retrospective Cohort Study

Frontiers in Pharmacology, 2022
Background: Limited data are available regarding the entire spectrum of interstitial lung disease with a progressive fibrosing feature. We investigated the prevalence and prognostic predictive characteristics in patients with PF-ILD.Methods: This ...
Yuanying Wang, Ziyun Guo, Ruimin Ma, Jingwei Wang, Na Wu, Na Wu, Yali Fan, Qiao Ye, Qiao Ye   +8 more
doaj   +1 more source

Interstitial lung disease [PDF]

European Respiratory Review, 2013
This article reviews the most important articles published in interstitial lung disease, as reviewed during the Clinical Year in Review session at the 2012 annual European Respiratory Society Congress in Vienna, Austria.Since the recent international guidelines for the management of idiopathic pulmonary fibrosis (IPF), important new evidence is ...
openaire   +4 more sources

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis [PDF]

, 2019
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome.
박무석, 이상훈
core   +1 more source

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges. [PDF]

, 2022
Patients with progressive fibrosing interstitial lung diseases (fILD) have increased morbidity and mortality. Lung fibrosis can be associated with lung cancer.
Jacques Cadranel, Cadranel, Jacques, Kewalramani, Namrata, Athol U. Wells, Machahua, Carlos, Manuela Funke-Chambour, Poletti, Venerino, Funke-Chambour, Manuela, Carlos Machahua, Wells, Athol U, Wells, Athol U., Namrata Kewalramani, Venerino Poletti   +12 more
core   +2 more sources

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis

Respiratory Research, 2022
Background Hypersensitivity pneumonitis (HP) is a type of interstitial lung disease (ILD) with a variable disease course and prognosis ranging from inflammatory and self-limiting to irreversible and progressive pulmonary fibrosis.
Thomas Skovhus Prior, Julia Wälscher, Benjamin Gross, Elisabeth Bendstrup, Michael Kreuter   +4 more
doaj   +1 more source

Telomerase Reverse Transcriptase Polymorphism rs2736100: A Balancing Act between Cancer and Non-Cancer Disease, a Meta-Analysis

Frontiers in Medicine, 2018
The enzyme telomerase reverse transcriptase (TERT) is essential for telomere maintenance. In replicating cells, maintenance of telomere length is important for the preservation of vital genetic information and prevention of genomic instability.
Reinier Snetselaar, Matthijs F. M. van Oosterhout, Jan C. Grutters, Jan C. Grutters, Coline H. M. van Moorsel, Coline H. M. van Moorsel   +5 more
doaj   +1 more source

ANXA11 rs1049550 Associates with Löfgren’s Syndrome and Chronic Sarcoidosis

Cells, 2022
Sarcoidosis is an immune mediated granulomatous disease commonly affecting the lungs. Genome wide association studies identified many genomic regions that are shared among multiple immune mediated diseases.
Bekir Karakaya, Joanne J. van der Vis, Marcel Veltkamp, Douwe H. Biesma, Jan C. Grutters, Coline H. M. van Moorsel   +5 more
doaj   +1 more source

Genetic Interstitial Lung Disease [PDF]

Clinics in Chest Medicine, 2012
The interstitial lung diseases (ILDs), or diffuse parenchymal lung diseases, are a heterogeneous collection of more than 100 different pulmonary disorders that affect the tissue and spaces surrounding the alveoli. Patients affected by ILD usually present with shortness of breath or cough; for many, there is evidence of pulmonary restriction, decreased ...
Megan Stuebner, Devine, Christine Kim, Garcia   +1 more
openaire   +2 more sources